DocMorris Aktie
WKN DE: A0Q6J0 / ISIN: CH0042615283
|
10.04.2024 07:00:13
|
DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card
|
DocMorris AG / Key word(s): Market Launch Frauenfeld, 10 April 2024
Press release
DocMorris receives gematik approval for simple digital e-prescription redemption via health card
DocMorris today successfully completed the process for product and provider approval for the fully digital redemption of e-prescriptions via the electronic health card (eGK = elektronische Gesundheitskarte) and received the corresponding approval from gematik. DocMorris eHealth-CardLink therefore fulfils all the requirements set by gematik as the responsible regulator for eHealth-CardLink solutions. The roll-out of the new e-prescription function in the DocMorris app was started immediately. “The e-prescription has now largely replaced the traditional pink paper prescription. Around 70 per cent of all prescriptions in Germany are already issued electronically. But until now, there has been no simple, fully digitalised way to redeem prescriptions that works from anywhere. That is now changing. We are the first authorised provider for the eHealth-CardLink solution and are counting on it to win over many patients. The e-prescription is an elementary component of our DocMorris healthcare ecosystem, with which we want to offer everyone the simplest and most reliable healthcare possible,” says Walter Hess, CEO of DocMorris. The simple redemption process via eGK in the DocMorris app Highest safety standards E-prescription enables convenient services The new way of redeeming e-prescriptions also makes it possible to provide even better care for chronically ill patients with long-term medication. They can sign up for a follow-up prescription subscription and thus ensure a seamless supply of important medicines. And last but not least, e-prescriptions also allow doctors to issue and send prescriptions to their patients as part of telemedical care. Further information can be found at: E-prescription for medication information | DocMorris
Investors and analyst contact Media contact Agenda
DocMorris
End of Inside Information |
| Language: | English |
| Company: | DocMorris AG |
| Walzmühlestrasse 49 | |
| 8500 Frauenfeld | |
| Switzerland | |
| ISIN: | CH0042615283 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1876919 |
| End of Announcement | EQS News Service |
|
|
1876919 10-Apr-2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DocMorris AG (ex Zur Rose)mehr Nachrichten
|
14.11.25 |
Börse Zürich in Rot: SPI liegt am Freitagmittag im Minus (finanzen.at) | |
|
13.11.25 |
DocMorris gibt die Ergebnisse des Rückkaufangebots für die ausstehenden Wandelanleihen mit Fälligkeit 2026 bekannt (EQS Group) | |
|
07.11.25 |
SPI-Titel DocMorris-Aktie: So viel hätten Anleger an einem DocMorris-Investment von vor 5 Jahren verloren (finanzen.at) | |
|
06.11.25 |
DocMorris kündigt Beginn der Rückkaufangebotsfrist für die ausstehenden Wandelanleihen mit Fälligkeit 2026 an (EQS Group) | |
|
31.10.25 |
SPI-Papier DocMorris-Aktie: So viel Verlust hätte ein DocMorris-Investment von vor 3 Jahren eingefahren (finanzen.at) | |
|
28.10.25 |
Minuszeichen in Zürich: SPI schwächelt mittags (finanzen.at) | |
|
28.10.25 |
Börse Zürich in Rot: SPI notiert zum Handelsstart im Minus (finanzen.at) | |
|
24.10.25 |
SPI-Titel DocMorris-Aktie: So viel Verlust hätte eine DocMorris-Investition von vor einem Jahr eingebracht (finanzen.at) |
Analysen zu DocMorris AG (ex Zur Rose)mehr Analysen
| 11.11.25 | DocMorris Sell | UBS AG | |
| 17.10.25 | DocMorris Hold | Deutsche Bank AG | |
| 17.10.25 | DocMorris Sell | UBS AG | |
| 16.10.25 | DocMorris Sell | UBS AG | |
| 16.10.25 | DocMorris Add | Baader Bank |
Aktien in diesem Artikel
| DocMorris AG (ex Zur Rose) | 5,47 | -4,95% |
|